[
    {
        "other_ids": [],
        "amendment_date": null,
        "keywords": [
            "ImmTAC",
            "Immunotherapy",
            "Bispecific T cell receptor fusion protein",
            "Immune mobilizing monoclonal T cell receptor against cancer",
            "Checkpoint inhibitor",
            "PD1 / PD-1",
            "PD-L1 / PDL1"
        ],
        "dcp_id": null,
        "interventional_model": "SEQUENTIAL_ASSIGNMENT",
        "lead_org": "Immunocore Ltd",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 0,
                    "description": "ECOG PS 0 or 1"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 1,
                    "description": "HLA-A*02:01 positive"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 2,
                    "description": "PRAME positive tumor"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 3,
                    "description": "Relapsed from, refractory to, or intolerant of standard therapy"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 4,
                    "description": "If applicable, must agree to use highly effective contraception"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 5,
                    "description": "Capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the Informed Consent (ICF) and protocol"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 6,
                    "description": "Symptomatic or untreated central nervous system metastasis"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 7,
                    "description": "Recent bowel obstruction"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 8,
                    "description": "Ascites requiring recurrent paracentesis"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 9,
                    "description": "Significant immune-mediated adverse event with prior immunotherapy (patients in combination treatment)"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 10,
                    "description": "Inadequate washout from prior anticancer therapy"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 11,
                    "description": "Significant ongoing toxicity from prior anticancer treatment"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 12,
                    "description": "Out-of-range laboratory values"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 13,
                    "description": "Clinically significant medical condition"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 14,
                    "description": "Ongoing requirement for immunosuppressive treatment"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 15,
                    "description": "Prior solid organ or bone marrow transplant"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 16,
                    "description": "Active hepatitis B virus (HBV) or hepatitis C virus (HCV) infection"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 17,
                    "description": "Known history of human immunodeficiency virus (HIV)"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 18,
                    "description": "Significant secondary malignancy"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 19,
                    "description": "Hypersensitivity to study drug or excipients"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 20,
                    "description": "Antibiotics, vaccines or surgery within 2-4 weeks prior to the first dose of study intervention"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 21,
                    "description": "Pregnant or lactating"
                }
            ],
            "structured": {
                "max_age": "999 Years",
                "max_age_number": 999.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 999.0,
                "gender": "BOTH",
                "accepts_healthy_volunteers": false,
                "min_age": "18 Years",
                "min_age_number": 18.0,
                "min_age_in_years": 18.0
            }
        },
        "completion_date_type_code": "ANTICIPATED",
        "detail_description": "The IMC-F106C-101 Phase 1/2 study will be evaluated in patients with metastatic/unresectable\r\n      tumors which include select Advanced Solid Tumors and will be conducted in two phases.\r\n\r\n        1. Phase 1: To identify the Maximum Tolerated Dose (MTD) and/or Recommended Phase 2 dose\r\n           (RP2D) of IMC-F106C as a single agent (Arm A) and administered in combination with\r\n           Checkpoint Inhibitors (Arm B).\r\n\r\n        2. Phase 2: To assess the preliminary anti-tumor activity of IMC-F106C as a single agent\r\n           administration.",
        "official_title": "Phase 1/2 Study of IMC-F106C in Advance PRAME-Positive Cancers",
        "_phase_sort_order": 3,
        "collaborators": [],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "approximately 3 weeks",
                "name": "Changes in lymphocyte counts over time",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "approximately 3 weeks",
                "name": "Changes in serum cytokines over time",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "from first dose to approximately 2 years",
                "name": "Duration of response (DOR)",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "approximately 2 years",
                "name": "Incidence of anti-IMC-F106C antibody formation",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "from first dose to approximately 2 years",
                "name": "Overall survival",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "approximately 3 weeks (IMC-F106C AUC will be assessed for ~3 weeks)",
                "name": "Pharmacokinetics Area under the plasma concentration-time curve (AUC)",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "approximately 3 weeks (IMC-F106C t1/2 will be assessed for ~ 3 weeks)",
                "name": "Pharmacokinetics The elimination half-life (t1/2)",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "approximately 3 weeks (IMC-F106C Cmax will be assessed for ~3 weeks)",
                "name": "Pharmacokinetics The maximum observed plasma drug concentration (Cmax)",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "approximately 3 weeks (IMC-F106C Tmax will be assessed for ~3 weeks)",
                "name": "Pharmacokinetics The time to reach maximum plasma concentration (Tmax)",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "from first dose to 30 days after the last dose",
                "name": "Phase 1: changes in electrocardiogram parameters",
                "description": "QTcF interval absolute values and changes from baseline will be summarized",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "from first dose to 30 days after the last dose",
                "name": "Phase 1: changes in laboratory parameters",
                "description": "Number of participants with, and rate of, Grade 1, Grade 2, Grade 3, and Grade 4 (as applicable per NCI CTCAE v5.0) laboratory abnormalities",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "from first dose to 30 days after the last dose",
                "name": "Phase 1: changes in vital signs",
                "description": "Number of participants with, and rate of, Grade 1, Grade 2, Grade 3, and Grade 4 (as applicable per NCI CTCAE v5.0) vital sign abnormalities",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "from first dose through last dose (anticipated for up to 12 months)",
                "name": "Phase 1: dose interruptions, reductions, and discontinuations",
                "description": "Number of participants with, and rate of, dose interruption, dose reduction, permanent discontinuation of study treatment Number of participants with, and rate of, dose interruption, dose reduction, permanent discontinuation of study treatment due to adverse event Number of participants with, and rate of, dose interruption, dose reduction, permanent discontinuation of study treatment due to treatment-related adverse event",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "from first dose to 30 days after the last dose",
                "name": "Phase 1: incidence and severity of adverse events (AE) and serious adverse events (SAE)",
                "description": null,
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "From first dose to DLT period (28 days)",
                "name": "Phase 1: Incidence of Dose-limiting toxicity (DLT)s",
                "description": null,
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "from first dose to approximately 2 years",
                "name": "Phase 2: Best overall response (BOR)",
                "description": null,
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "from first dose to approximately 2 years",
                "name": "Phase I: Best Overall Response (BOR)",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "from first dose to approximately 2 years",
                "name": "Progression-free survival (PFS)",
                "description": null,
                "type_code": "SECONDARY"
            }
        ],
        "phase": "I_II",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 3,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT04262466",
        "biomarkers": [
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Class I MHC",
                    "MHC Class I"
                ],
                "nci_thesaurus_concept_id": "C16617",
                "name": "MHC Class I Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C25790",
                    "C16612",
                    "C16812"
                ],
                "parents": [
                    "C16812"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "HLA-A*02 Positive",
                    "HLA-A*02 Positive Cells Present",
                    "HLA-A*2 Positive",
                    "HLA-A02 Allele Positive",
                    "HLA-A02 Positive",
                    "HLA-A2 Positive"
                ],
                "nci_thesaurus_concept_id": "C69408",
                "name": "HLA-A2 Positive Cells Present",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C3367",
                    "C177692",
                    "C25790",
                    "C16617",
                    "C28585",
                    "C77140",
                    "C35682",
                    "C36292",
                    "C16812"
                ],
                "parents": [
                    "C177692",
                    "C28585"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "HLA Complex Gene"
                ],
                "nci_thesaurus_concept_id": "C16812",
                "name": "Major Histocompatibility Complex Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C25790"
                ],
                "parents": [
                    "C25790"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Expressed",
                    "Expression Detected"
                ],
                "nci_thesaurus_concept_id": "C177692",
                "name": "Expression Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C36292",
                    "C35682",
                    "C77140"
                ],
                "parents": [
                    "C35682"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "HLA-A",
                    "Major Histocompatibility Complex, Class I, A Gene"
                ],
                "nci_thesaurus_concept_id": "C28585",
                "name": "HLA-A Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C25790",
                    "C16612",
                    "C16812",
                    "C16617"
                ],
                "parents": [
                    "C16617"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Genes"
                ],
                "nci_thesaurus_concept_id": "C16612",
                "name": "Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "branch"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "HLA-A*0201 Positive"
                ],
                "nci_thesaurus_concept_id": "C129450",
                "name": "HLA Class I Histocompatibility Antigen, A-0201 Alpha Chain Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16617",
                    "C28585",
                    "C3367",
                    "C77140",
                    "C16612",
                    "C16812",
                    "C36292",
                    "C25790",
                    "C177692",
                    "C35682"
                ],
                "parents": [
                    "C177692",
                    "C28585"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "PRAME",
                    "Preferentially Expressed Antigen in Melanoma Gene"
                ],
                "nci_thesaurus_concept_id": "C127928",
                "name": "PRAME Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C54362",
                    "C16612"
                ],
                "parents": [
                    "C54362"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Positive",
                    "positive test result"
                ],
                "nci_thesaurus_concept_id": "C35682",
                "name": "Positive Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C36292",
                    "C77140"
                ],
                "parents": [
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "LAB_RESULT",
                    "Lab Findings",
                    "Laboratory Finding",
                    "Laboratory Report",
                    "Labs",
                    "Test Result",
                    "test_result"
                ],
                "nci_thesaurus_concept_id": "C36292",
                "name": "Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "HLA-A*0201 Positive",
                    "HLA-A*02:01 Positive Cells Present"
                ],
                "nci_thesaurus_concept_id": "C69178",
                "name": "HLA-A*0201 Positive Cells Present",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16617",
                    "C28585",
                    "C77140",
                    "C3367",
                    "C16612",
                    "C16812",
                    "C36292",
                    "C129450",
                    "C25790",
                    "C177692",
                    "C35682",
                    "C69408"
                ],
                "parents": [
                    "C129450",
                    "C28585",
                    "C69408"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "CT130 Positive",
                    "Cancer/Testis Antigen 130 Positive",
                    "MAPE Positive",
                    "Melanoma Antigen Preferentially Expressed in Tumors Positive",
                    "OIP-4 Positive",
                    "OIP4 Positive",
                    "Opa-Interacting Protein 4 Positive",
                    "PRAME Expression Positive",
                    "Preferentially Expressed Antigen in Melanoma Positive"
                ],
                "nci_thesaurus_concept_id": "C133814",
                "name": "PRAME Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C3367",
                    "C127928",
                    "C177692",
                    "C54362",
                    "C77140",
                    "C35682",
                    "C36292"
                ],
                "parents": [
                    "C127928",
                    "C177692"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C54362",
                "name": "Transcription Regulation Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Diagnostic Test Result",
                    "Test Result"
                ],
                "nci_thesaurus_concept_id": "C77140",
                "name": "Clinical Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367"
                ],
                "parents": [
                    "C3367"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25790",
                "name": "Immunoprotein Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Observable Entity"
                ],
                "nci_thesaurus_concept_id": "C3367",
                "name": "Finding",
                "semantic_types": [
                    "Finding"
                ],
                "type": [
                    "branch"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            }
        ],
        "classification_code": null,
        "current_trial_status_date": "2020-02-25",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrent Malignant Solid Neoplasm",
                    "Recurrent Solid Neoplasm",
                    "Relapsed Solid Tumor",
                    "Recurrent Solid Tumor",
                    "Relapsed Malignant Solid Neoplasm",
                    "Relapsed Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C127153",
                "name": "Recurrent Malignant Solid Tumor",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C132146",
                    "C4813"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [
                    "Advanced Malignant Solid Neoplasm",
                    "Advanced Non-Hematologic Malignancy",
                    "Advanced Solid Neoplasm",
                    "Advanced Solid Tumor"
                ],
                "nci_thesaurus_concept_id": "C129707",
                "name": "Advanced Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C127155",
                    "C9270"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Refractory Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C133737",
                "name": "Refractory Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C120186",
                    "C132146"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Solid Neoplasm",
                    "Metastatic Solid Tumor",
                    "Metastatic Tumor",
                    "Metastatic Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C127155",
                "name": "Metastatic Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C132146"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Solid Tumour",
                    "Solid tumor, NOS",
                    "Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C9292",
                "name": "Solid Tumor",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Advanced Cancer"
                ],
                "nci_thesaurus_concept_id": "C9270",
                "name": "Advanced Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Malignancy",
                    "Secondary Cancer"
                ],
                "nci_thesaurus_concept_id": "C4968",
                "name": "Secondary Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C36255"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Tumor",
                    "Tumor, metastatic",
                    "Neoplasm, metastatic"
                ],
                "nci_thesaurus_concept_id": "C3261",
                "name": "Metastatic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Cancer"
                ],
                "nci_thesaurus_concept_id": "C36263",
                "name": "Metastatic Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C3261"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Disease",
                    "Diseases and Disorders",
                    "disease type",
                    "Disease or Disorder",
                    "Diagnosis",
                    "disease_term",
                    "condition",
                    "disease_type",
                    "Diseases",
                    "Disease or Disorder, Non-Neoplastic",
                    "Disorders",
                    "Disorder"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C132146",
                "name": "Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9292",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasms, NOS",
                    "Neoplasia",
                    "Tumor, NOS",
                    "Neoplastic Growth",
                    "Neoplasm",
                    "Neoplastic Disease",
                    "tumor",
                    "Neoplasm, NOS"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, secondary",
                    "Secondary Tumor",
                    "Tumor, secondary"
                ],
                "nci_thesaurus_concept_id": "C36255",
                "name": "Secondary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Malignant Growth",
                    "Tumor, malignant, NOS",
                    "Malignant Tumor",
                    "Malignancy",
                    "CA",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrence",
                    "Recurrent Cancer",
                    "Recurrent Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C4813",
                "name": "Recurrent Malignant Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C9305",
                    "C4798"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Refractory Tumor"
                ],
                "nci_thesaurus_concept_id": "C7628",
                "name": "Refractory Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "resistant cancer",
                    "Refractory Cancer",
                    "clinical resistance"
                ],
                "nci_thesaurus_concept_id": "C120186",
                "name": "Refractory Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C7628"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrence",
                    "Recurrent",
                    "Recurrent Tumor",
                    "Neoplasm Recurrence"
                ],
                "nci_thesaurus_concept_id": "C4798",
                "name": "Recurrent Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7062"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "IMC-F106C-101",
        "active_sites_count": 6,
        "lead_org_cancer_center": null,
        "arms": [
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunomodulators",
                            "Immunotherapy Agent",
                            "BRM",
                            "Immunomodulatory Agent",
                            "Immune Mediators",
                            "Immune Modulators",
                            "Immune Regulators",
                            "Immunopotentiators",
                            "Biomodulators",
                            "Immunotherapeutic Agent",
                            "Immunomodulating Agent",
                            "Biological Response Modifier"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Pharmacological Treatments",
                            "Pharmacological Treatment",
                            "Drug Therapy",
                            "Treatment With Medication"
                        ],
                        "nci_thesaurus_concept_id": "C15986",
                        "name": "Pharmacotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C49236"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Chemotherapy, Cancer, General",
                            "Chemo"
                        ],
                        "nci_thesaurus_concept_id": "C15632",
                        "name": "Chemotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C49236"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Biotherapy",
                            "Biological Response Modifiers Therapy",
                            "Biologics Therapies",
                            "Biological Response Modifier Therapy"
                        ],
                        "nci_thesaurus_concept_id": "C15187",
                        "name": "Biological Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C49236"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunologically Directed Therapy"
                        ],
                        "nci_thesaurus_concept_id": "C15262",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C15187"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C131060",
                        "name": "Checkpoint Blockade Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C15438"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Biological Products",
                            "Biologics",
                            "Biopharmaceuticals",
                            "Immunologics",
                            "Biologicals",
                            "Immunologic, Immunochemical"
                        ],
                        "nci_thesaurus_concept_id": "C307",
                        "name": "Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Drug",
                            "Pharmaceuticals",
                            "Agent",
                            "Pharmacological Substance",
                            "Drug Substance",
                            "Pharmaceutical Agent",
                            "Pharmacologic Agent"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C43431",
                        "name": "Activity",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Intervention Strategies",
                            "Intervention",
                            "Procedure"
                        ],
                        "nci_thesaurus_concept_id": "C25218",
                        "name": "Intervention or Procedure",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C16203"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C16203",
                        "name": "Clinical or Research Activity",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C43431"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Monoclonal Antibodies",
                            "Monoclonal Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C20401",
                        "name": "Monoclonal Antibody Therapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C307",
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C170976",
                        "name": "Anti-PRAME T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-F106C",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C20401"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Therapeutic Interventions",
                            "Therapeutic Method",
                            "Therapeutic Technique",
                            "Therapy"
                        ],
                        "nci_thesaurus_concept_id": "C49236",
                        "name": "Therapeutic Procedure",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C25218"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immuno-Chemotherapy",
                            "immunotherapy for cancer",
                            "Immunotherapy, Cancer, General"
                        ],
                        "nci_thesaurus_concept_id": "C15438",
                        "name": "Cancer Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C15262",
                            "C15986",
                            "C15632"
                        ]
                    }
                ],
                "name": "Arm not specified",
                "description": null,
                "type": null
            },
            {
                "interventions": [],
                "name": "IMC-F106C and an anti-PD(L)1 agent - Arm B - Phase 1",
                "description": "Dose Escalation",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "IMC-F106C - Arm A - Phase 1",
                "description": "Dose Escalation",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "IMC-F106C - Phase 2",
                "description": "Monotherapy dose expansion",
                "type": "EXPERIMENTAL"
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2020-02152",
        "why_study_stopped": null,
        "brief_summary": "IMC-F106C is an immune-mobilizing T cell receptor against cancer (ImmTAC \u00ae) designed for the\r\n      treatment of cancers positive for the tumor-associated antigen PRAME. This is a\r\n      first-in-human trial designed to evaluate the safety and efficacy of IMC-F106C in adult\r\n      patients who have the appropriate HLA-A2 tissue marker and whose cancer is positive for PRAME",
        "brief_title": "Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors",
        "status_history": [
            {
                "status_date": "2020-02-25T00:00:00",
                "status": "ACTIVE"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 170,
        "_current_trial_status_sort_order": 0,
        "start_date": "2020-02-25",
        "record_verification_date": "2022-03-01",
        "ctep_id": null,
        "current_trial_status": "Active",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": null,
            "role_investigator": null,
            "role_outcome_assessor": null,
            "role_subject": null,
            "allocation_code": "Non-Randomized Trial"
        },
        "acronym": null,
        "nci_funded": "Indirect",
        "anatomic_sites": [
            "Multiple"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": null,
        "study_source": "Industrial",
        "completion_date": "2026-02-01",
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]